Anne B. Cropp

3.9k total citations · 2 hit papers
13 papers, 2.8k citations indexed

About

Anne B. Cropp is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anne B. Cropp has authored 13 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne B. Cropp's work include Heart Failure Treatment and Management (6 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Anne B. Cropp is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Anne B. Cropp collaborates with scholars based in United States, Netherlands and Chile. Anne B. Cropp's co-authors include Milton Packer, Milton L. Pressler, Santosh Sutradhar, Bertram Pitt, Aldo P. Maggioni, Mark D. Sullivan, Douglas L. Mann, Stefan D. Anker, Dariush Mozaffarian and Inder S. Anand and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Anne B. Cropp

13 papers receiving 2.7k citations

Hit Papers

The Seattle Heart Failure Model 1996 2026 2006 2016 2006 1996 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Seattle Heart Failure Model
    2006 1.5k citations Wayne C. Levy, Dariush Mozaffarian et al. Circulation profile →
  2. Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure
    1996 808 citations Milton Packer, Christopher M. O’Connor et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne B. Cropp United States 8 2.3k 472 352 338 189 13 2.8k
J Korewicki Poland 17 2.9k 1.2× 445 0.9× 223 0.6× 344 1.0× 284 1.5× 67 3.4k
Charles Porter United States 18 2.2k 0.9× 564 1.2× 270 0.8× 256 0.8× 282 1.5× 38 3.1k
A. Mosterd Netherlands 7 2.3k 1.0× 313 0.7× 169 0.5× 250 0.7× 228 1.2× 9 2.8k
Wendy A. Gattis United States 26 2.7k 1.2× 359 0.8× 303 0.9× 673 2.0× 211 1.1× 77 3.5k
Jonathan Sackner‐Bernstein United States 17 2.6k 1.1× 290 0.6× 300 0.9× 444 1.3× 96 0.5× 45 3.2k
Guillermo Cintrón United States 13 2.8k 1.2× 474 1.0× 229 0.7× 368 1.1× 128 0.7× 27 3.3k
Keith Michl United States 4 3.4k 1.5× 570 1.2× 377 1.1× 560 1.7× 294 1.6× 6 4.1k
Jindřich Špinar Czechia 24 2.2k 1.0× 928 2.0× 603 1.7× 253 0.7× 229 1.2× 117 3.1k
Mihai Gheorghiade United States 22 1.9k 0.8× 348 0.7× 177 0.5× 578 1.7× 131 0.7× 43 2.6k
James C. Fang United States 27 2.1k 0.9× 547 1.2× 297 0.8× 315 0.9× 210 1.1× 69 3.0k

Countries citing papers authored by Anne B. Cropp

Since Specialization
Citations

This map shows the geographic impact of Anne B. Cropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne B. Cropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne B. Cropp more than expected).

Fields of papers citing papers by Anne B. Cropp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne B. Cropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne B. Cropp. The network helps show where Anne B. Cropp may publish in the future.

Co-authorship network of co-authors of Anne B. Cropp

This figure shows the co-authorship network connecting the top 25 collaborators of Anne B. Cropp. A scholar is included among the top collaborators of Anne B. Cropp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne B. Cropp. Anne B. Cropp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Schnaper, H. William, Joseph T. Flynn, Coleman Gross, et al.. (2017). Enhancing clinical trial development for pediatric kidney diseases. Pediatric Research. 82(5). 727–732. 3 indexed citations
2.
Dai, Haiqing, et al.. (2012). The pharmacokinetics and pharmacodynamics of PF-00734200, a DPP-IV inhibitor, in healthy Japanese subjects. International Journal of Clinical Pharmacology and Therapeutics. 50(7). 505–509. 2 indexed citations
3.
Getz, Kenneth, et al.. (2011). Measuring the Incidence, Causes, and Repercussions of Protocol Amendments. Drug Information Journal. 45(3). 265–275. 45 indexed citations
4.
Mohler, Emile R., Srinivas Mantha, Alan B. Miller, et al.. (2007). Should troponin and creatinine kinase be routinely measured after vascular surgery?. Vascular Medicine. 12(3). 175–181. 6 indexed citations
5.
Levy, Wayne C., Dariush Mozaffarian, David T. Linker, et al.. (2006). The Seattle Heart Failure Model. Circulation. 113(11). 1424–1433. 1461 indexed citations breakdown →
6.
Fleisher, Lee A., Mark F. Newman, Anne B. Cropp, et al.. (2005). Efficacy of Zoniporide, an Na/H Exchange Ion Inhibitor, for Reducing Perioperative Cardiovascular Events in Vascular Surgery Patients. Journal of Cardiothoracic and Vascular Anesthesia. 19(5). 570–576. 11 indexed citations
7.
Cabell, Christopher H., Benjamin H. Trichon, Eric J. Velazquez, et al.. (2003). Importance of echocardiography in patients with severe nonischemic heart failure: the second prospective randomized amlodipine survival evaluation (PRAISE-2) echocardiographic study. American Heart Journal. 147(1). 151–157. 19 indexed citations
8.
Neuberg, Gerald W., Alan B. Miller, Chris O’Connor, et al.. (2002). Diuretic resistance predicts mortality in patients with advanced heart failure. American Heart Journal. 144(1). 31–38. 286 indexed citations
9.
O’Connor, Christopher M., Peter E. Carson, Alan B. Miller, et al.. (1998). Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trial. The American Journal of Cardiology. 82(7). 881–887. 63 indexed citations
10.
Neuberg, Gerald W., Chris O’Connor, Alan B. Miller, et al.. (1998). High diuretic doses are associated with sudden death in patients with advanced heart failure: The PRAISE trial. Journal of Cardiac Failure. 4(3). 34–34. 2 indexed citations
11.
Mohler, Emile R., Jalal K. Ghali, Douglas D. Schocken, et al.. (1997). Role of Cytokines in the Mechanism of Action of Amlodipine: The PRAISE Heart Failure Trial. Journal of the American College of Cardiology. 30(1). 35–41. 97 indexed citations
12.
Pressler, Milton L., Peter E. Carson, Alan B. Miller, et al.. (1996). Safety of amiodipine in severe heart failure: Reduction of sudden death in non-ischemic heart disease. Journal of the American College of Cardiology. 27(2). 281–281. 3 indexed citations
13.
Packer, Milton, Christopher M. O’Connor, Jalal K. Ghali, et al.. (1996). Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure. New England Journal of Medicine. 335(15). 1107–1114. 808 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Korewicki Breakdown of academic impact, for papers by Charles Porter Breakdown of academic impact, for papers by A. Mosterd Breakdown of academic impact, for papers by Wendy A. Gattis Breakdown of academic impact, for papers by Jonathan Sackner‐Bernstein Breakdown of academic impact, for papers by Guillermo Cintrón Breakdown of academic impact, for papers by Keith Michl Breakdown of academic impact, for papers by Jindřich Špinar Breakdown of academic impact, for papers by Mihai Gheorghiade Breakdown of academic impact, for papers by James C. Fang
Rankless by CCL
2026